ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹98 Cr |
Mar2023 | ₹69 Cr |
Mar2022 | ₹74 Cr |
Mar2021 | ₹45 Cr |
Mar2020 | ₹44 Cr |
How is Total Non-Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹98 Cr | 41.80 | |
Mar2023 | ₹69 Cr | -6.30 | |
Mar2022 | ₹74 Cr | 65.09 | |
Mar2021 | ₹45 Cr | 1.07 | |
Mar2020 | ₹44 Cr | - |
Compare Total Non-Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹18,757.0 Cr | 3.3% | 5.8% | 16.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 3.3% |
5.8% |
16.2% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses